Objective: Insulin seems to have vasodilator properties, but it is unclear if insulin in postprandial concentrations is a specific vasodilator of skeletal muscle resistance arterioles only or that various types of vessels are affected. The aim of the present study was to determine the direct effects and the time course of regionalrlocal physiological hyperinsulinemia on skeletal muscle arterioles, skin blood Ž . flow and peripheral venous tone and the reponsiveness of these different vascular beds to noradrenaline. Methods: In protocol 1 n s 12 Ž . Ž . Ž . we infused insulin into the brachial artery for 180 min 3.5 mUrmin and evaluated the effects on forearm muscle blood flow FBF Ž . Ž . Ž . and skin blood flow SBF . Furthermore, noradrenaline 0.025, 0.01 and 0.4 mgrmin was infused i.a. at baseline, at 90 and 180 min Ž . after the start of insulin. In protocol 2 n s 10 the same regional forearm hyperinsulinemia was achieved, but now the local venous Ž . responsiveness to noradrenaline 1.7-55 ngrmin, at baseline and at 90 and 180 min was measured in a dorsal hand vein. In protocol 3 Ž . we evaluated the local effects of different doses of insulin 1-100 mUrmin infused directly into hand veins preconstricted with Ž . Ž phenylephrine. Results: Forearm hyperinsulinemia f 50 mUrl led to a significant increase in FBF after 180 min median 26%, interq.
Introduction
Epidemiological studies demonstrate an association between obesity, non-insulin-dependent diabetes mellitus Ž . w x NIDDM , and hypertension 1,2 . Several experimental studies suggest that insulin not only lowers blood glucose w x levels but also acts as a vasodilator 3-7 . Impaired insulin vasodilation has been observed in insulin-resistant states w x such as NIDDM, hypertension and obesity 3,5,8 . The impaired vasodilator properties of insulin could result in elevated vascular tone and augmented responses to vasoconstrictors culminating in increased peripheral resistance.
lates the production of endothelium-derived nitric oxide Ž .w x EDNO 10,11 . Both in vivo and in vitro studies indicate that supraphysiological doses of insulin can induce vasodilation in blood vessels from various vascular beds, includw x ing resistance arterioles, conduit arteries and veins [12] [13] [14] [15] . Therefore, it is still unresolved whether insulin, in concen-Ž trations as can be found in humans after a meal postpran-. dial , is a specific vasodilator of skeletal muscle resistance arterioles or, alternatively, that various types of vessels are affected. Besides its direct vasodilating properties insulin Ž . in healthy subjects also seems to attenuate the constrictor response of the forearm vasculature or peripheral veins to vasoconstrictors, such as noradrenaline and angiotensin II, w x which could affect blood pressure homeostasis 12,14-16 . However, other authors could not observe any effect of w x insulin on noradrenergic responsiveness 17,18 . Apart from the type of vessel affected by insulin, the time span in which insulin can accomplish its hemodynamic effects in the various vascular beds has received relatively little attention. During systemic hyperinsulinemia the increase in forearm as well as leg flow seems to Ž .w x have a relatively slow onset a few hours 8, [19] [20] [21] [22] . In contrast, local infusion of insulin directly into veins rew x sulted in marked vasodilation within minutes 14, 23, 24 . If insulin, in physiological concentrations, is indeed a potent and rapidly acting venodilator, it could play a pivotal role in postprandial volume and blood pressure regulation.
The aim of the present study was to determine the effect and time course of local physiological hyperinsulinemia during a few hours on different types of vessel in the Ž human forearm, skeletal muscle arterioles, skin micro-. vascular blood flow and hand veins, and their constrictor responses to noradrenaline. To minimize influences of systemic neurohormonal and metabolic changes on regional hemodynamics, insulin was infused regionally into the brachial artery or directly into a single vein.
Methods

Subjects
Three series of experiments were performed in a total of 36 healthy normotensive male subjects with a mean age of Ž . 22 " 2 years mean " s.d. , body mass index of 21.8 " 2.7 2 Ž . kgrm and intra-arterial blood pressure of 116r74 mmHg. Fasting blood glucose values were 4.0 " 0.3 mmolrl. No subject had evidence of metabolic or cardiovascular disease and no subject had a family history of diabetes mellitus, hypertension or cardiovascular diseases.
Ž . Subjects did not use any medication including NSAID's and refrained from smoking and caffeine for at least 12 h before the experiment. All studies were conducted in the morning after an overnight fast and subjects were studied supine in a hospital bed, in a quiet, temperature-controlled room.
The nature, purpose, and potential risks of the study were carefully explained to each subject before informed consent to participate was obtained. All participants gave written informed consent and the studies were approved by the Ethical Review Committee of the University Hospital Maastricht. The investigation conforms with the principles outlined in the Declaration of Helsinki.
Techniques
Intra-arterial forearm study
Before starting the experiment forearm volume was measured by water displacement. Subjects were studied supine; mean room temperature was 24.4 " 0.58C. Fore-Ž . arm muscle and skin blood flow were measured as w x described previously 25 . In short, thermoregulatory skin Ž . blood flow SBF was measured using laser-Doppler Ž . fluxmetry Periflux PF3; Perimed, Jarfalla, Sweden . The probes were placed on the ventral side of both forearms near the wrists. These probes remained in the same position throughout the experiment. Flux values are expressed Ž . as arbitrary perfusion units PU , calibrated against an Ž . external standard. Forearm blood flow FBF was determined in both arms simultaneously using ECG-triggered Ž strain-gauge venous occlusion plethysmography Periflow;
. Janssen Scientific Instruments, Beerse, Belgium . The hand circulation was excluded during the FBF measurement by inflating a wrist cuff to suprasystolic pressure, starting 1 min before each FBF measurement. Hence, FBF measurements predominantly represent muscle blood flow. Intraarterial blood pressure was measured using a Hewlett Packard pressure dome and 78205C monitor. Heart rate was determined from the ECG.
Venous studies: Linear Õariable differential transformer
Venous responsiveness was assessed by the linear vari-Ž . able differential transformer LVDT technique, which measures alterations in the distension of superficial hand w x veins during drug infusions 26 . Subjects were studied supine in a temperature-controlled room, mean temperature 26.0 " 0.58C which was necessary in order to minimize sympathetic tone. In the non-dominant arm a dorsal hand vein was cannulated with a 23-gauge butterfly needle. This arm was resting on a padded support, 30 degrees above the horizontal, so that the vein, which was above heart level, was completely collapsed. A cuff was attached around the upper arm. Changes in vein diameter were measured using Ž the LVDT model 100 HMR, Schaevitz Engineering, . Ž Pennsauken, NJ and an ATA signal conditioner Schae-. vitz Engineering . The LVDT was mounted on the back of the hand using a tripod. The tip of the steel core of the LVDT was positioned over the center of the vein approximately 1 cm proximal to the tip of the butterfly needle. After an acclimatisation period of 30 min, 3 baseline measurements of venous distension were performed with a 
Experimental protocols ( ) 2.3.1. Protocol 1 FBF, forearm hyperinsulinemia
In this first series of experiments the vasoactive effects of regional hyperinsulinemia on thermoregulatory skin per-Ž . fusion and forearm blood flow were studied n s 12 . Two catheters were inserted in the cubital fossa of the nondominant arm: a 20-gauge catheter into the brachial artery Ž . retrogradely, after local anesthesia with lidocaine for Ž . infusion of insulin Actrapid, Novo-Nordisk, Denmark Ž and noradrenaline Centrafarm, Etten-Leur, The Nether-. lands , and a 21-gauge catheter into an antecubital vein Ž . antegradely for blood sampling. After an acclimatisation period of 30 min baseline measurements of SBF, FBF and intra-arterial blood pressure were performed. After 15 min, these measurements were repeated before and during infusion of 3 cumulative doses of noradrenaline: 0.025, 0.1 and 0.4 mgrmin, each dose for 3 min. Thereafter, an intra-Ž . arterial infusion of insulin 3.5 mUrmin was started Ž . ts0 for 180 min. At t s 45, 90, 135 and 180 min the hemodynamic measurements were repeated; at t s 90 and 180 min, noradrenaline was again administered in 3 cumulative doses. Before each hemodynamic measurement, venous blood from the infused arm was drawn to determine local insulin values. Systemic blood glucose levels were determined in arterial blood from the same arm.
( ) 2.3.2. Protocol 2 LVDT, forearm hyperinsulinemia
Ž In protocol 2, protocol 1 intra-arterial infusion of in-. sulin was repeated, but now the venodilator effect of 3 h hyperinsulinemia on the dorsal hand vein was determined. Ž . Ž . Insulin n s 10 or saline n s 8 was infused into the brachial artery of the non-dominant arm. In this arm also a dorsal hand vein was cannulated with a butterfly needle and the LVDT was positioned as described above. After an acclimatisation period of 30 min, basal distension and the vasoconstrictor response of the hand vein to a stepped Ž . infusion of NA 1.7-5.5-17-55 ngrmin , administered directly into the vein, was measured at t s 0, 90 and 180 min. At these time-points arterial blood glucose and venous insulin levels of the infused arm were also determined.
( ) 2.3.3. Protocol 3 LVDT, local hyperinsulinemia
In order to study the local effect of different doses of insulin, a third series of experiments was performed in Ž . protocol 3 n s 14 . First, a cumulative stepped infusion of Ž . phenylephrine PE was administered directly into a dorsal Ž . hand vein 10-10 000 ngrmin, each dose for 6 min . After Ž . a wash-out period 35 min vessels were preconstricted to Ž . approximately 80% ED of the maximal PE constric-80 Ž tion, calculated using non-linear curve-fitting Graphpad . Software Inc. . Subsequently, a cumulative stepped infu-Ž . sion of insulin 1-3-10-30-100 mUrmin was administered. Each insulin dose was infused for 6 min and venous distension was determined during the last 2 min. In these experiments PE instead of NA was used, as in pilot studies using NA it was more difficult to obtain a stable preconstriction. During all experiments the infused volume was Ž . kept constant 0.3 mlrmin . Blood pressure and blood glucose levels were measured before the start of the PE infusion and during both the highest PE and insulin dose.
Analytical and statistical procedures
Blood glucose was determined by the glucose-oxidase Ž method on the YSI Model 2300 Stat Yellow Springs, OH, . USA . Total insulin was determined by a commercial Ž . radio-immunoassay Pharmacia, Uppsala, Sweden . Noradrenaline, phenylephrine and insulin were dissolved in saline. In addition, a small amount of blood was added to the insulin solution to prevent the adhesion of insulin to the plastic syringe and tubing. All solutions were freshly prepared immediately prior to the experiment.
For each measurement period the ratios of SBF and Ž FBF were calculated infused arm divided by the contralat-. eral arm . These calculated ratios correct for all systemic factors that affect the regulation of blood flow in both Ž arms e.g., changes in blood pressure, level of arousal, . hormonal changes etc. , and ensure that only the direct effects of locally infused substances on the forearm blood w x flow are taken into account 27 . To determine the effect of hyperinsulinemia on SBF, FBF and blood pressure the mean value of the last minute of each period was used for calculations. The distribution of the FBF, SBF and hand vein data was not normal, so a non-parametric Friedman two-way ANOVA test was used to evaluate differences in the dose-response curves, followed by a post-hoc nonparametric Wilcoxon test to examine the differences between the various parameters. Shaffer correction was used w x for multiple comparisons 28 . Data are expressed as medians and interquartile ranges, unless indicated otherwise. Statistical significance was set at a value P -0.05%.
Results
During all studies systemic blood glucose concentration did not change, nor did systemic blood pressure and heart Ž . rate data not shown . min of hyperinsulinemia FBF ratio had increased signifi-Ž . cantly by 25.8% 5.0-49.8, P -0.05, Fig. 1 . Forearm vascular responses to insulin showed a wide variability: at t s 180 min the change in FBF ratio was between y13 and 70% in all subjects. No changes in FBF were found in Ž . 3 subjects non-responders, increase in FBF ratio F 0% , although no differences were observed in forearm insulin Ž . concentrations between responders n s 9 and non-re-Ž . sponders n s 3 . The forearm vasoconstrictor response to Ž noradrenaline expressed as percentage decrease of FBF . ratio was not modified at t s 90 and t s 180 min of Ž . hyperinsulinemia intrabrachial insulin infusion were somewhat lower compared with protocol 1. The higher room temperature in Ž . protocol 2 26.0 vs 24.58C probably resulted in a relative vasodilation, with an increase in intrabrachial blood flow. Very likely, this led to a greater dilution of the infused insulin, with subsequent lower venous insulin levels. No changes were observed in baseline venous diameter during Ž intra-brachial infusion of insulin or placebo data not . shown . Local venous NA administration resulted in a dose-dependent decrease of venous diameter during all experiments. In comparison to t s 0, no changes in venous diameter were observed during NA administration at t s 90 and t s 180 min in either insulin or placebo experiments Ž . Fig. 3 . 
( ) 3.3. Protocol 3 LVDT, local hyperinsulinemia
In Fig. 4 the dose-response curve of insulin infused directly into the dorsal hand vein is depicted. Local insulin administration resulted in a minor dose-dependent increase in venous diameter, only during the highest dose of insulin Ž w x . 7% 2-13 , P -0.05 . In 4 of the 14 subjects insulin did Ž not affect venous diameter increase in venous diameter . F 0% . 
Discussion
The results of the present study indicate that regional Ž . physiological hyperinsulinemia approx. 40-50 mUrl in-Ž . duced a moderate increase in muscle blood flow FBF with a slow onset. Forearm constrictor responses to noradrenaline were not affected. In contrast to the increase in Ž . muscle blood flow, skin blood flow SBF was not modified and only minor vasodilator effects were found in hand Ž . veins during the highest dose of insulin .
Impaired insulin-mediated vasodilation could be one of the common characteristics of NIDDM, obesity and hyperw x tension 3,5,8,20 . The mechanism by which insulin exerts its vasodilator effect is not fully understood, especially because of the uncertainty which vascular beds are involved. Another complication is that the studies in which insulin is infused systemically are difficult to interpret, given the complex systemic changes that occur in circulating metabolitesrhormones and central nervous system acw x tivity 6 . Furthermore, studies with systemic hyperinsulinemia have a duration of several hours and are, therefore, possibly confounded by diurnal rhythms in peripheral blood w x flow 29 . In an earlier study we showed that FBF gradually increases by approx. 60% during the day without any w x changes in the ratio of blood flow in both arms 29 . Thus, regional intrabrachial infusion with the use of the contralateral arm as control, enabling the calculation of the ratio of FBF in both arms, probably circumvents these problems. Until now, local studies in which insulin was infused directly into the brachial artery or into a vein have been difficult to reconcile: a very slow vasodilation in forearm studies in contrast to the rapid and very marked w x vasodilation in dorsal hand vein studies 14,23,24 .
Insulin-mediated Õasodilation in the forearm
Laakso et al. reported a dose-dependent increase of peripheral blood flow during systemic hyperinsulinemia Ž . euglycemic clamp in humans, with a half-maximal rew x sponse at insulin levels of approximately 40 mUrl 5,8 . However, several other authors did not observe a change in peripheral blood flow during less than 2 h intrabrachial w x infusion of insulin 7,9,30,31 . Given the slow onset of insulin-mediated vasodilation, as observed in the present study, the time span of these experiments may have been too short.
In the present study local hyperinsulinemia resulted in a Ž . modest 26% increase in muscle blood flow after 3 h, while skin perfusion and venous tone did not change. These data confirm a recent study of Utriainen et al. who concluded that increased peripheral blood flow is based w x upon vasodilation in skeletal muscle, but not in skin 19 . Baron et al. postulated that this insulin-mediated vasodilaw x tion potentiates peripheral glucose uptake 32 . However, postprandial hyperinsulinemia usually has returned to baseline after 3 h. The slow onset of vasodilation in the present study suggests that longer periods of postprandial hyperinsulinemia or possibly higher concentrations are necessary to have more relevant physiological effects on peripheral blood flow. However, after a meal not only insulin but also blood glucose concentration rises. During an euglycemic hyperinsulinemic clamp insulin-mediated vasodilation dew x pends upon the ambient glucose concentration 20,33 . Preliminary data from our group suggest that local hyperglycemia can augment the stimulation of forearm blood Ž . w x flow by insulin approx. 70% increase in FBF ratio 34 , w x whereas glucose per se does not affect FBF 35 . Further studies are necessary to determine the role of the postprandial rise in insulin and glucose concentration in the regulation of skeletal blood flow.
The FBF data in the present study indicate that there is a relatively wide variability in insulin-mediated vasodilation in man. In 3 of the 12 subjects no vasodilation could be observed, although the insulin concentrations of the non-responders and responders were similar. Given the very slow onset of insulin-mediated vasodilation, the time span of this experimental protocol could have been too short in the 3 non-responders. Several authors have reported that insulin-mediated vasodilation is impaired in various related disorders such as obesity, hypertension and w x NIDDM 3,4,8,20 . However, all subjects were normotensive, non-obese and normoglycemic. Furthermore, all had a negative family history for hypertension and diabetes mellitus. The vasodilatory effect of insulin is probably w x related to stimulation of NO release 11 . Therefore, the observed variability in insulin-mediated vasodilation could be the consequence of variability in NO release.
Noradrenaline in the forearm
Several authors reported that intrabrachial infusion of insulin into the human forearm results in an attenuated constrictor response to both adrenergic and non-adrenergic w x stimuli 9,29,30 . However, we could not demonstrate any Ž . effect of insulin approx. 45 mUrl on the forearm constrictor responses to noradrenaline. Also Tack et al. could not observe an effect of insulin on forearm vasculature responses to either local adminstered exogenous or sysw x temic endogenous released noradrenaline 17,18 . Differences in experimental protocol could explain some of the discrepancies between the various studies. However, it should be stressed that different results can be obtained when forearm constrictor responses are analysed in another way. In several studies the constrictor response is expressed in absolute terms as change in FBF of the infused Ž . arm dFBF . When our data are analysed similarly, we also find significant differences in NA responsiveness during hyperinsulinemia: dFBF during the highest dose of noradrenaline was y0.67 mlrdlrmin at t s 0 and y1.67 Ž . at t s 180 min t s 0 vs ts180 min, P -0.01 . Absolute changes in FBF in response to constrictors or dilators, however, do not take into account that the diameter of the vasculature studied could affect its subsequent response to a vasoactive drug. The data should, therefore, be analysed as the percentage change in FBF, which corrects for differences in baseline vascular tone. Finally, when forearm responses to local infusion of vasoactive drugs are w x evaluated, both arms should be taken into account 27 . As mentioned before in Section 2, the calculated FBF ratio corrects for all systemic factors that affect the regulation of Ž blood flow in both arms e.g., changes in blood pressure, . level of arousal, hormonal changes etc. , and ensures that only the direct effects of locally infused substances on the forearm blood flow are taken into account. For instance, when expressed as percentage change in FBF ratio, forearm noradrenergic responsiveness remains unaltered during 24 h in healthy volunteers, and is not affected by w x variations in blood flow or blood pressure 25 .
Insulin and noradrenaline in the hand Õein
A common disadvantage of most dorsal hand vein studies is the unknown local insulin concentration w x 14,23,24 . In most of the insulin studies, veins are preconstricted first, as they have very little basal tone. Extremely high local insulin concentrations can easily be reached as the insulin is infused into a very small volume with a low Ž . flow. In the present study protocol 2 , insulin was infused into the brachial artery, resulting in comparable physiological insulin concentrations in skeletal muscle, skin and peripheral veins. This hyperinsulinemia in the hand vein did not affect either the basal venous distension or the venoconstrictor responses to noradrenaline. In contrast, insulin infused directly into dorsal hand veins resulted in a rapid but minor venodilation only during the highest dose of insulin, which is in agreement with other authors w x 14,23,24 . In a protocol in which higher concentrations of insulin were administered, Feldman et al. found an even more marked venodilatation, in veins preconstricted with w x phenylephrine 23 . In some studies the achieved insulin concentration must have been supraphysiological, because Ž . oral glucose had to be administered to prevent systemic w x hypoglycemia 23,24 . An additional confounder is that in most hand vein studies the drugs were dissolved in 5% glucose. When infused in dorsal hand veins, 5% glucose w x can induce an aspecific venodilation 36 . If insulin were indeed a potent rapid venodilator, one would expect that it lowers venous return, and would probably lead to a decreased cardiac output during hyperinsulinemia. However, such a decrease in cardiac ouput has never been reported. Several authors, on the other hand, have found that cardiac w x output rises during systemic hyperinsulinemia 37,38 . Ž Thus, from the physiological point of view, it is in our . opinion unlikely that insulin is a potent venodilator.
Conclusion
In conclusion, the present study suggests that insulin within the physiological range increases peripheral blood flow by vasodilating skeletal muscle resistance arterioles.
